TITLE:
Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

CONDITION:
Cervical Cancer

INTERVENTION:
V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine

SUMMARY:

      The primary purpose of the study is to determine if an investigational vaccine Gardasil
      (V501) with 4 components will provide an immune response and will be well tolerated in
      pre-adolescents and adolescents.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 10 Years to 23 Years
Criteria:

        Inclusion Criteria:

          -  Healthy adolescents and pre-adolescents with no prior sexual history

          -  Healthy women who have an intact uterus with lifetime history of 0-4 sexual partners

        Exclusion Criteria:

          -  Prior Human Papillomavirus (HPV) vaccination

          -  Prior abnormal Paps

          -  Prior history of genital warts
      
